Skip to main content
Log in

Nekrotisierende Fasziitis durch Acinetobacter baumannii

Ein Fallbericht

Necrotizing fasciitis caused by Acinetobacter baumannii

A case report

  • Kasuistiken
  • Published:
Der Hautarzt Aims and scope Submit manuscript

Zusammenfassung

Es wird über einen 42-jährigen Patienten mit einer nekrotisierenden Fasziitis am rechten Bein berichtet. In mehreren tiefen Wundabstrichen gelang der Nachweis eines multiresistenten Acinetobacter-baumanii-Stammes. Die Therapie mit Imipenem und Tobramycin sowie ausgedehnte Nekrektomien führten zu einer langsamen Besserung der Symptomatik. Acinetobacter baumannii kommt zunehmend Bedeutung als Erreger nosokomialer Infektionen, insbesondere auf Intensivstationen, zu.

Abstract

A 42-year-old man developed necrotizing fasciitis on the right leg. A multidrug-resistant Acinetobacter baumannii was cultivated from the deep wound. Following therapy with imipenem and tobramycin as well as extensive debridement, the lesions improved slowly. A. baumannii is today an important cause of nosocomial infections, especially in intensive care units.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2

Literatur

  1. Siegrist HH (2000) Acinetobacter spp. Nosokomiale Infektionen, Epidemiologie und Antibiotikaresistenz. Swiss-NOSO 7:6–7

  2. Andrew P (2008) Molecular basis of acinetobacter virulence and pathogenicity. In: Gerischer U (Hrsg) Acinetobacter molecular biology. Caister Academic

  3. Centers for Disease Control and Prevention (2004) Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002–2004. Morb Mortal Wkly Rep 53:1063–1066

    Google Scholar 

  4. Cisneros JM, Reyes MJ, Pachón J et al (1996) Bacteremia due to acinetobacter baumannii: epidemiology, clinical findings and prognostic features. Clin Infect Dis 22:1026–1032

    CAS  PubMed  Google Scholar 

  5. Forster DH, Daschner FD (1998) Acinetobacter species as nosocomial pathogens. Eur J Clin Microbiol Infect Dis 17:73–77

    CAS  PubMed  Google Scholar 

  6. Bergogne-Bérézin E, Towner KJ (1996) Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 9:148–165

    PubMed  Google Scholar 

  7. Rahal J (2006) Novel antibiotic combinations against infections with almost completely resistant pseudomonas aeruginosa and acinetobacter species. Clin Infect Dis 43(Suppl 2):S95–S99

    Article  CAS  PubMed  Google Scholar 

  8. Coelho JM, Turton JF, Kaufmann ME et al (2006) Occurrence of carbapenem-resistant acinetobacter baumannii clones at multiple hospitals in London and Southeast England. J Clin Microbiol 40:3623–3627

    Article  Google Scholar 

  9. Karageorgopoulos DE, Falagas ME (2008) Current control and treatment of multidrug-resistant acinetobacter baumannii infections. Lancet Infect Dis 8:751–762

    Article  PubMed  Google Scholar 

  10. Bassetti M, Righi E, Esposito S et al (2008) Drug treatment for multidrug-resistant acinetobacter baumannii infections. Future Microbiol 3:649–660

    Article  CAS  PubMed  Google Scholar 

  11. Hillert R (2009) Polymyxine. In: Ackermann G (Hrsg) Antibiotika und Antimykotika. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, S 150–153

  12. Gounden R, Bamford C, Zyl-Smit R van et al (2009) Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant acinetobacter baumannii infections. BMC Infect Dis 9(9):26

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J.A. Wagner.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wagner, J., Nenoff, P., Handrick, W. et al. Nekrotisierende Fasziitis durch Acinetobacter baumannii . Hautarzt 62, 128–130 (2011). https://doi.org/10.1007/s00105-010-1962-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-010-1962-3

Schlüsselwörter

Keywords

Navigation